Urinary orosomucoid 1 protein to creatinine ratio as a potential biomarker for early screening of kidney impairment in type-2 diabetes patients

Nephrology (Carlton). 2020 Sep;25(9):667-675. doi: 10.1111/nep.13707. Epub 2020 Mar 24.

Abstract

Background: Early screening of diabetic kidney disease (DKD) remains a major challenge. Our aim was to evaluate the value of urinary orosomucoid 1 protein (UORM1) in early renal impairment screening in type-2 diabetes patients.

Methods: The concentration of UORM1, the UORM1-to-creatinine ratio (UORM1CR), the urinary albumin-to-creatinine ratio (ACR), the alpha-1-microglobulin-to-creatinine ratio (A1MCR) and estimated glomerular filtration rate (eGFR) were measured in 406 type-2 diabetes patients. Any positive values for ACR, A1MCR and/or eGFR were considered as indicative of renal impairment.

Results: On average, the levels of UORM1 and UORM1CR were about seven times higher in subjects with renal injury than in those without. Both UORM1 and UORM1CR, when adjusted via logarithm-transformation, were significantly related to ACR, A1MCR and eGFR levels. The highest correlation was observed between UORM1CR and A1MCR (r = 0.85, P < .001). The cut-off values for UORM1 (2.53 mg/L) and UORM1CR (3.69 mg/g) for the early diagnosis of kidney impairment were obtained from receiver operating characteristic curves. UORM1CR obviously had higher diagnostic efficiency corresponding to 83.26% sensitivity and 90.32% specificity than UORM1. Likewise, its sensitivity was higher than those of ACR, A1MCR and eGFR. Bad glycaemic control had the highest risk of increased UORM1CR (odds ratio [OR] = 2.81, P < .001), while high HDL-C (high-density lipoprotein cholesterol) decreased the risk of increased UORM1CR (OR = 0.38, P = .017).

Conclusion: The UORM1CR (>3.69 mg/g) has the high diagnostic efficiency for the early screening of renal impairment in type-2 diabetes patients. Furthermore, good glycaemic control and high HDL-C might be protective factors against UORM1CR increase.

Keywords: diagnostic efficiency; kidney impairment; type 2 diabetes; urinary orosomucoid 1 protein to creatinine ratio.

MeSH terms

  • Alpha-Globulins / analysis
  • Biomarkers / urine
  • China / epidemiology
  • Cholesterol, HDL / blood
  • Correlation of Data
  • Creatinine / analysis
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / epidemiology
  • Diabetes Mellitus, Type 2* / metabolism
  • Diabetes Mellitus, Type 2* / physiopathology
  • Diabetic Nephropathies* / diagnosis
  • Diabetic Nephropathies* / epidemiology
  • Diabetic Nephropathies* / etiology
  • Diabetic Nephropathies* / metabolism
  • Early Diagnosis
  • Female
  • Glomerular Filtration Rate
  • Glycemic Control / methods*
  • Humans
  • Male
  • Middle Aged
  • Orosomucoid / urine*
  • Protective Factors
  • Risk Factors
  • Urinalysis / methods

Substances

  • Alpha-Globulins
  • Biomarkers
  • Cholesterol, HDL
  • Orosomucoid
  • alpha-1-microglobulin
  • Creatinine